[1]
Shahidsales, S. et al. 2024. Study of Osteopontin as the “CA125” Adjunct for Detection of Ovarian Carcinoma in Patients with Pelvic Mass. Reports of Radiotherapy and Oncology. 10, 2 (Nov. 2024), 59–64.